BiomX Inc. (NYSEAMERICAN:PHGE) Short Interest Update

BiomX Inc. (NYSEAMERICAN:PHGEGet Free Report) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 25,400 shares, a growth of 159.2% from the February 13th total of 9,800 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average daily volume of 89,200 shares, the short-interest ratio is currently 0.3 days.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and issued a $2.00 price target on shares of BiomX in a research note on Wednesday, January 8th.

View Our Latest Research Report on PHGE

BiomX Stock Performance

Shares of PHGE traded down $0.00 during midday trading on Friday, hitting $0.60. The company had a trading volume of 15,141 shares, compared to its average volume of 80,366. The company has a market capitalization of $10.91 million, a P/E ratio of -0.19 and a beta of 1.27. BiomX has a 52 week low of $0.48 and a 52 week high of $4.99.

About BiomX

(Get Free Report)

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).

Featured Articles

Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.